NovaBay Pharmaceuticals, Inc. (NBY)
NYSEAMERICAN: NBY · Real-Time Price · USD
0.681
-0.039 (-5.42%)
At close: Nov 22, 2024, 4:00 PM
0.671
-0.010 (-1.42%)
After-hours: Nov 22, 2024, 7:34 PM EST
NovaBay Pharmaceuticals Employees
As of December 31, 2023, NovaBay Pharmaceuticals had 26 total employees, including 24 full-time and 2 part-time employees. The number of employees decreased by 7 or -21.21% compared to the previous year.
Employees
26
Change (1Y)
-7
Growth (1Y)
-21.21%
Revenue / Employee
$532,462
Profits / Employee
-$637,115
Market Cap
3.33M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Oncternal Therapeutics | 30 |
| Bio-Path Holdings | 10 |
| Palisade Bio | 9 |
| Virpax Pharmaceuticals | 7 |
| Synaptogenix | 5 |
| Oragenics | 5 |
| Lixte Biotechnology Holdings | 4 |
| Titan Pharmaceuticals | 4 |
NBY News
- 12 hours ago - NovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024 - Business Wire
- 7 days ago - Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals' Proposals to Authorize the Sale of its Avenova Brand - Business Wire
- 15 days ago - NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results - Business Wire
- 16 days ago - NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price - Business Wire
- 24 days ago - NovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC - Business Wire
- 2 months ago - Acumen Health Holdings ("Acumen") to Acquire the Avenova brand from NovaBay Pharmaceuticals - PRNewsWire
- 2 months ago - NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets - Business Wire
- 3 months ago - NovaBay Pharmaceuticals, Inc. (NBY) Q2 2024 Earnings Call Transcript - Seeking Alpha